Works matching DE "CYTOCHROME P-450 CYP2C19"

Results: 312

Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling Approach.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 7, p. 1047, doi. 10.1007/s40262-025-01517-0

By:

Helfer, Victória E.;
Gonzalez, Daniel;
Kyler, Kathryn E.;
Dunlap, Tyler C.;
Williams, Veronica;
Radford, Jansynn;
Selvarangan, Rangaraj;
Sasidharan, Anjana;
Chan, Sherwin;
Artz, Nathan;
Retke, Brandon;
Toren, Paul;
Gibson, Kim;
Shakhnovich, Valentina

Publication type:

Article

Changes in S‐Citalopram Plasma Concentrations Across Pregnancy and Postpartum.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 106, doi. 10.1002/cpt.3642

By:

Stika, Catherine S.;
Avram, Michael J.;
George, Alfred L.;
Yang, Amy;
Ciolino, Jody D.;
Jeong, Hyunyoung;
Venkataramanan, Raman;
Caritis, Steve N.;
Costantine, Maged M.;
Wisner, Katherine L.

Publication type:

Article

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-02872-5

By:

Priyadharshini, A.;
Vijayakumar, T. M.;
Damodharan, N.;
Vasanth, K. M.;
Elaiyaraja, Arun

Publication type:

Article

The Frequency of CYP2C19&ast;2 Gene Polymorphisms in Burkina Faso Patients Treated with Clopidogrel.

Published in:

Application of Clinical Genetics, 2025, v. 18, p. 55, doi. 10.2147/TACG.S509095

By:

Kagambèga, Yves Donald;
Ouattara, Abdoul Karim;
Ouédraogo, Teega-Wendé Clarisse;
Traoré, Lassina;
Yaméogo, Nobila Valentin;
Simpore, Jacques

Publication type:

Article

Molecular Ancestry Across Allelic Variants of SLC22A1 , SLC22A2 , SLC22A3 , ABCB1 , CYP2C8 , CYP2C9 , and CYP2C19 in Mexican-Mestizo DMT2 Patients.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1156, doi. 10.3390/biomedicines13051156

By:

Ortega-Ayala, Adiel;
de la Cruz, Carla González;
Dorado, Pedro;
Rodrigues-Soares, Fernanda;
Castillo-Nájera, Fernando;
LLerena, Adrián;
Molina-Guarneros, Juan

Publication type:

Article

艾可清对药物代谢酶活性及对洛匹那韦与利托那韦的大鼠血浆药代动力学参数的影响.

Published in:

Traditional Chinese Drug Research & Clinical Pharmacology, 2024, v. 35, n. 7, p. 1046, doi. 10.19378/j.issn.1003-9783.2024.07.013

By:

何晓峰;
卢元媛;
陈剑涛;
符林春;
沈小玲;
胡英杰

Publication type:

Article

Perkütan koroner gı̇rı̇şı̇m sonrası klopı̇dogrel dı̇rencı̇nı̇n CYP2C9 ve CYP2C19 genlerı̇nı̇n kopya sayısı varyasyonu ile ı̇lı̇şkı̇sı̇

Published in:

Mersin Üniversitesi sağlık Bilimleri Dergisi, 2024, v. 17, n. 2, p. 262, doi. 10.26559/mersinsbd.1392360

By:

Ayaz, Lokman;
Şahin, Seyhan;
Sancar, Hilal

Publication type:

Article

The role of CYP2C19*2 variant and other factors in clopidogrel resistance in Montenegrin ACS patients.

Published in:

Genetics & Applications, 2024, v. 8, n. 2, p. 54, doi. 10.31383/ga.vol8iss2ga03

By:

Perović, Svetlana;
Vujović, Slavica;
Perović, Saša;
Šćepanović, Anđelka

Publication type:

Article

The impact of CYP2C19 genotypes on steady-state plasma concentration of escitalopram in South Indian population with Major Depressive Disorder.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e123645

By:

Kumar, B. Jeevan;
Mahalingam, Vijayakumar Thangavel;
M, Ganesh Kumar

Publication type:

Article

Effects of the EM CYP2C19 type and MDR1 3435CC gene on Helicobacter pylori eradication rate in patients with duodenal ulcer by the four-drug regimen of rabeprazole, bismuth, tetracycline, and tinidazole.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e108090

By:

Nguyen, Liem T.;
Nguyen, Vuong B.;
Tran, Tu V.;
Le, Loan T. T.;
Phuong, Mai H. T.;
Nguyen, Thang

Publication type:

Article

Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 755, doi. 10.1111/bcpt.14095

By:

Abouir, Kenza;
Varesio, Emmanuel;
Déglon, Julien;
Samer, Caroline;
Daali, Youssef

Publication type:

Article

Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 2, p. 217, doi. 10.1111/bcpt.14040

By:

Jørgensen, Steffen;
Brodersen, Thorsten;
Vesterager Pedersen, Ole Birger;
Westergaard, Niels

Publication type:

Article

Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 5, p. 756, doi. 10.1111/bcpt.13990

By:

Houlind, Morten Baltzer;
Hansen, Luise;
Iversen, Esben;
Rasmussen, Henrik Berg;
Larsen, Jens Borggaard;
Jørgensen, Steffen;
Dalhoff, Kim;
Damkier, Per;
Walls, Anne B.;
Vermehren, Charlotte;
Andersen, Trine Rune Høgh;
Kallemose, Thomas;
Christrup, Lona;
Westergaard, Niels

Publication type:

Article

Drug metabolism and drug transport of the 100 most prescribed oral drugs.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 5, p. 311, doi. 10.1111/bcpt.13780

By:

Iversen, Ditte B.;
Andersen, Nanna Elman;
Dalgård Dunvald, Ann‐Cathrine;
Pottegård, Anton;
Stage, Tore B.

Publication type:

Article

Ticagrelor is more effective than clopidogrel in carrier of nonfunctional CYP2C19 allele who has diabetes and acute coronary syndrome - case report and literature review.

Published in:

AIMS Molecular Science, 2022, v. 9, n. 2, p. 66, doi. 10.3934/molsci.2022004

By:

Tekeste, Rahel;
Garza, Gregorio;
Song Han;
Jianli Dong

Publication type:

Article

The Evaluation of CYP2D6, CYP2C9, CYP2C19 , and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 5, p. 661, doi. 10.3390/metabo13050661

By:

Giorgetti, Arianna;
Amurri, Sara;
Fazio, Giulia;
Bini, Carla;
Anniballi, Laura;
Pirani, Filippo;
Pelletti, Guido;
Pelotti, Susi

Publication type:

Article

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 1, p. 45, doi. 10.3390/metabo13010045

By:

Fliszár-Nyúl, Eszter;
Ungvári, Orsolya;
Dombi, Ágnes;
Özvegy-Laczka, Csilla;
Poór, Miklós

Publication type:

Article

Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 10, p. 1001, doi. 10.3390/metabo12101001

By:

Sychterz, Caroline;
Gardner, Iain;
Chiang, Manting;
Rachumallu, Ramakrishna;
Neuhoff, Sibylle;
Perera, Vidya;
Merali, Samira;
Schmidt, Brian J.;
Gaohua, Lu

Publication type:

Article

Differential Expression of Serum Proinflammatory Cytokine TNF-α and Genetic Determinants of TNF-α, CYP2C19*17, miR-423 Genes and Their Effect on Coronary Artery Disease Predisposition and Progression.

Published in:

Life (2075-1729), 2023, v. 13, n. 11, p. 2142, doi. 10.3390/life13112142

By:

Almassabi, Rehab F.;
Mir, Rashid;
Javid, Jamsheed;
AbuDuhier, Faisel M.;
Almotairi, Reema;
Alhelali, Marwan H.;
Algehainy, Naseh;
Alsaedi, Basim S. O.;
Albalawi, Salem Owaid;
Elfaki, Imadeldin

Publication type:

Article

10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis.

Published in:

Helicobacter, 2021, v. 26, n. 5, p. 1, doi. 10.1111/hel.12833

By:

Zou, Pei‐Ying;
Hu, Jie;
Zhao, Jing‐Tao;
Zhao, Zhe;
Mei, Hao;
Yang, Jing;
Zhu, Yang‐Jie;
Zhang, Yi;
Lan, Chun‐Hui

Publication type:

Article

Development and validation of next-generation sequencing panel for personalized Helicobacter pylori eradication treatment targeting multiple species.

Published in:

Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1379790

By:

Min, Byung-Joo;
Seo, Myung-Eui;
Bae, Jung Ho;
Kim, Ji Won;
Kim, Ju Han

Publication type:

Article

Development and validation of next-generation sequencing panel for personalized Helicobacter pylori eradication treatment targeting multiple species.

Published in:

Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1379790

By:

Byung-Joo Min;
Myung-Eui Seo;
Jung Ho Bae;
Ji Won Kim;
Ju Han Kim

Publication type:

Article

Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Published in:

Genes, 2024, v. 15, n. 5, p. 607, doi. 10.3390/genes15050607

By:

Ganoci, Lana;
Palić, Jozefina;
Trkulja, Vladimir;
Starčević, Katarina;
Šimičević, Livija;
Božina, Nada;
Lovrić-Benčić, Martina;
Poljaković, Zdravka;
Božina, Tamara

Publication type:

Article

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia.

Published in:

Genes, 2023, v. 14, n. 10, p. 1945, doi. 10.3390/genes14101945

By:

Forbes, Malcolm;
Hopwood, Mal;
Bousman, Chad A.

Publication type:

Article

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners.

Published in:

Genes, 2023, v. 14, n. 10, p. 1841, doi. 10.3390/genes14101841

By:

van der Drift, Denise;
Simoons, Mirjam;
Koch, Birgit C. P.;
Brufau, Gemma;
Bindels, Patrick;
Matic, Maja;
van Schaik, Ron H. N.

Publication type:

Article

Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors.

Published in:

Genes, 2023, v. 14, n. 3, p. 578, doi. 10.3390/genes14030578

By:

Levens, Amar D.;
den Haan, Melina C.;
Jukema, J. Wouter;
Heringa, Mette;
van den Hout, Wilbert B.;
Moes, Dirk Jan A. R.;
Swen, Jesse J.

Publication type:

Article

The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics.

Published in:

Genes, 2021, v. 12, n. 11, p. 1758, doi. 10.3390/genes12111758

By:

Austin-Zimmerman, Isabelle;
Wronska, Marta;
Wang, Baihan;
Irizar, Haritz;
Thygesen, Johan H.;
Bhat, Anjali;
Denaxas, Spiros;
Fatemifar, Ghazaleh;
Finan, Chris;
Harju-Seppänen, Jasmine;
Giannakopoulou, Olga;
Kuchenbaecker, Karoline;
Zartaloudi, Eirini;
McQuillin, Andrew;
Bramon, Elvira

Publication type:

Article

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER<sup>+</sup> breast cancer.

Published in:

Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00332-7

By:

Boucenna, Amira;
Boudaoud, Khadidja;
Hireche, Ahmed;
Rezgoune, Mohamed Larbi;
Abadi, Noureddine;
Filali, Taha;
Satta, Dalila

Publication type:

Article

The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis.

Published in:

Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00313-w

By:

Alkattan, Abdullah N.;
Radwan, Nashwa M.;
Mahmoud, Nagla E.;
Alfaleh, Amjad F.;
Alfaifi, Amal H.;
Alabdulkareem, Khaled I.

Publication type:

Article

The Correlation of Two Different Real-Time PCR Devices for the Analysis of CYP2C19 Pharmacogenetic Results.

Published in:

Scientia Pharmaceutica, 2023, v. 91, n. 4, p. 51, doi. 10.3390/scipharm91040051

By:

Alonso Llorente, Alba;
Salgado Garrido, Josefa;
Teijido Hermida, Oscar;
González Andrade, Fabricio;
Valiente Martín, Alberto;
Fanlo Villacampa, Ana;
Vicente Romero, Jorge

Publication type:

Article

Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19 / CYP2D6 genes play a role? A UK population-based study.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 4, p. 396, doi. 10.1177/02698811231152748

By:

Richards-Belle, Alvin;
Austin-Zimmerman, Isabelle;
Wang, Baihan;
Zartaloudi, Eirini;
Cotic, Marius;
Gracie, Caitlin;
Saadullah Khani, Noushin;
Wannasuphoprasit, Yanisa;
Wronska, Marta;
Dawda, Yogita;
Osborn, David PJ;
Bramon, Elvira

Publication type:

Article

Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro.

Published in:

Journal of Psychopharmacology, 2021, v. 35, n. 12, p. 1517, doi. 10.1177/02698811211050573

By:

Lan, Tian;
Ma, Ya-Qing;
Dang, Ya-Min;
Wang, Chen-Chen;
Xu, Ren-Ai;
Cai, Jian-Ping;
Hu, Guo-Xin

Publication type:

Article

Notable drug-drug interaction between omeprazole and voriconazole in CYP2C19 1 and 2 (rs4244285, 681G>A) alleles in vitro.

Published in:

Xenobiotica, 2024, v. 54, n. 10, p. 847, doi. 10.1080/00498254.2024.2421513

By:

Li, Xue

Publication type:

Article

The metabolism of the orexin-1 selective receptor antagonist nivasorexant.

Published in:

Xenobiotica, 2024, v. 54, n. 3, p. 124, doi. 10.1080/00498254.2024.2319811

By:

Treiber, Alexander;
Seeland, Swen;
Haschimi, Belal;
Weigel, Aude;
Williams, Jodi T.;
Gabillet, Jerome

Publication type:

Article

Physiologically based pharmacokinetic modelling to predict drug–drug interactions for encorafenib. Part I. Model building, validation, and prospective predictions with enzyme inhibitors, inducers, and transporter inhibitors.

Published in:

Xenobiotica, 2023, v. 53, n. 5, p. 366, doi. 10.1080/00498254.2023.2250856

By:

Kollipara, Sivacharan;
Ahmed, Tausif;
Praveen, Sivadasu

Publication type:

Article

The influence of temperature on the metabolic activity of CYP2C9, CYP2C19, and CYP3A4 genetic variants in vitro.

Published in:

Xenobiotica, 2023, v. 53, n. 5, p. 357, doi. 10.1080/00498254.2023.2248498

By:

Kojima, Michiaki;
Machida, Kanami;
Cho, Sumie;
Watanabe, Daichi;
Seki, Hiroyuki;
Shimoji, Miyuki;
Imaoka, Ayuko;
Yamazaki, Hiroshi;
Guengerich, F. Peter;
Nakamura, Katsunori;
Yamamoto, Koujirou;
Akiyoshi, Takeshi;
Ohtani, Hisakazu

Publication type:

Article

Physiologically based pharmacokinetic modeling (PBPK) to predict drug-drug interactions for encorafenib. Part II. Prospective predictions in hepatic and renal impaired populations with clinical inhibitors and inducers.

Published in:

Xenobiotica, 2023, v. 53, n. 5, p. 339, doi. 10.1080/00498254.2023.2246153

By:

Kollipara, Sivacharan;
Ahmed, Tausif;
Praveen, Sivadasu

Publication type:

Article

Spectroscopic observations of β-eudesmol binding to human cytochrome P450 isoforms 3A4 and 1A2, but not to isoforms 2C9, 2C19, and 2D6.

Published in:

Xenobiotica, 2022, v. 52, n. 2, p. 199, doi. 10.1080/00498254.2022.2037168

By:

Krenc, Dawid;
Na-Bangchang, Kesara

Publication type:

Article

Assessment of drug-drug interactions of CC-90001, a potent and selective inhibitor of c-Jun N-terminal kinase.

Published in:

Xenobiotica, 2021, v. 51, n. 12, p. 1416, doi. 10.1080/00498254.2022.2027553

By:

Tong, Zeen;
Gaudy, Allison;
Tatosian, Daniel;
Ramirez-Valle, Francisco;
Liu, Hong;
Chen, Jian;
Hoffmann, Matthew;
Surapaneni, Sekhar

Publication type:

Article

Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver.

Published in:

Xenobiotica, 2021, v. 51, n. 12, p. 1352, doi. 10.1080/00498254.2021.2007553

By:

Zhang, Yongjie;
Sato, Rei;
Fukami, Tatsuki;
Nakano, Masataka;
Nakajima, Miki

Publication type:

Article

Metabolic activation of aegeline mediated by CYP2C19.

Published in:

Xenobiotica, 2021, v. 51, n. 11, p. 1217, doi. 10.1080/00498254.2021.1913666

By:

Tian, Min;
Zhou, Shenzhi;
Li, Wei;
Li, Jiaru;
Yang, Lan;
Peng, Ying;
Zheng, Jiang

Publication type:

Article

Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies.

Published in:

Xenobiotica, 2021, v. 51, n. 10, p. 1199, doi. 10.1080/00498254.2021.1969481

By:

Huang, Feng-Ru;
Zhou, Chen;
Zhang, Xiao-Yan;
Shen, Ye;
Zhang, Hong-Wen;
Wang, Yong-Qing;
Sun, Lu-Ning

Publication type:

Article

Impact of single nucleotide polymorphisms (R132Q and W120R) on the binding affinity and metabolic activity of CYP2C19 toward some therapeutically important substrates.

Published in:

Xenobiotica, 2020, v. 50, n. 12, p. 1510, doi. 10.1080/00498254.2020.1786189

By:

Derayea, Sayed M.;
Tsujino, Hirofumi;
Oyama, Yukiko;
Ishikawa, Yoshinobu;
Yamashita, Taku;
Uno, Tadayuki

Publication type:

Article

Pharmacogenetics of P2Y<sub>12</sub> receptor inhibitors.

Published in:

Pharmacotherapy, 2023, v. 43, n. 2, p. 158, doi. 10.1002/phar.2758

By:

Thomas, Cameron D.;
Williams, Alexis K.;
Lee, Craig R.;
Cavallari, Larisa H.

Publication type:

Article

Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.

Published in:

Journal of the Canadian Association of Gastroenterology, 2024, v. 7, n. 3, p. 238, doi. 10.1093/jcag/gwae005

By:

Tai, Cheng-Chun;
Medwid, Samantha;
Mclntosh, Keith;
Chande, Nilesh;
Kim, Richard B;
Gregor, James

Publication type:

Article

Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221083674

By:

Zhang, Lijie;
Lv, Ying;
Dong, Jianyu;
Wang, Nana;
Zhan, Zhan;
Zhao, Yuan;
Jiang, Shanshan

Publication type:

Article

Model‐Informed Recommendation of Mavacamten Posology for Chinese Adults With Obstructive Hypertrophic Cardiomyopathy.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 4, p. 751, doi. 10.1002/psp4.13312

By:

Wu, Xiaojie;
Puli, Shilpa;
Chen, Nanye;
Tian, Zhuang;
Hsu, Peiwen;
Sun, Jing;
Lyu, Cheng;
Merali, Samira;
Zhang, Jing

Publication type:

Article

Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 12, p. 2150, doi. 10.1002/psp4.13228

By:

Yang, Eunsol;
Hwang, Inyoung;
Ji, Sang Chun;
Kim, John;
Lee, SeungHwan

Publication type:

Article

Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1462, doi. 10.1002/psp4.13197

By:

Chang, Peter;
Perera, Vidya;
Salinger, David H.;
Merali, Samira;
Thanneer, Neelima;
Back, Hyunmoon;
Seroogy, Julie D.;
Gretler, Daniel D.;
Sehnert, Amy J.;
Palmisano, Maria;
Roy, Amit

Publication type:

Article

Impact of obesity and roux‐en‐Y gastric bypass on the pharmacokinetics of (R)‐ and (S)‐omeprazole and intragastric pH.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 9, p. 1528, doi. 10.1002/psp4.13189

By:

Pippa, Leandro F.;
Vozmediano, Valvanera;
Mitrov‐Winkelmolen, Lieke;
Touw, Daan;
Soliman, Amira;
Cristofoletti, Rodrigo;
Salgado Junior, Wilson;
de Moraes, Natalia Valadares

Publication type:

Article